COMBIVIR

This brand name is authorized in United States. It is also authorized in Australia, Austria, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Japan, Lithuania, Mexico, Netherlands, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug COMBIVIR contains a combination of these active pharmaceutical ingredients (APIs):

1	Lamivudine UNII 2T8Q726O95 - LAMIVUDINE
	Lamivudine is a nucleoside analogue which has activity against human immunodeficiency virus (HIV) and hepatitis B virus (HBV). Its main mode of action is as a chain terminator of viral reverse transcription.
	Read more about Lamivudine
2	Zidovudine UNII 4B9XT59T7S - ZIDOVUDINE
	Zidovudine is an antiviral agent which is highly active in vitro against retroviruses including the Human Immunodeficiency Virus (HIV).
	Read more about Zidovudine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
COMBIVIR Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J05AR01	Zidovudine and lamivudine	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AR Antivirals for treatment of HIV infections, combinations
Discover more medicines within J05AR01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10284G
CA	Health Products and Food Branch	02239213
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00494433, 00499241, 00728954, 00789074, 00800947, 00970069, 02654970, 08725085, 10227880, 11710696
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	2946-MEE-0817
EE	Ravimiamet	1036460
ES	Centro de información online de medicamentos de la AEMPS	98058001
FI	Lääkealan turvallisuus- ja kehittämiskeskus	101916
FR	Base de données publique des médicaments	65521773
GB	Medicines & Healthcare Products Regulatory Agency	40280
HK	Department of Health Drug Office	63605
JP	医薬品医療機器総合機構	6250100F1032
LT	Valstybinė vaistų kontrolės tarnyba	1012168, 1028280, 1055421
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	095M98
NL	Z-Index G-Standaard, PRK	50059
PL	Rejestru Produktów Leczniczych	100088859
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65649001, W65649002
SG	Health Sciences Authority	10795P
TN	Direction de la Pharmacie et du Médicament	23013031
TR	İlaç ve Tıbbi Cihaz Kurumu	8699522096053
US	FDA, National Drug Code	49702-202
ZA	Health Products Regulatory Authority	32/20.2.8/0705